查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1737087

全球医疗物流市场规模（按服务、产品类型、区域覆盖范围和预测）

Global Healthcare Logistics Market Size By Service (Pharmaceutical Products, Medical Devices), By Product Type (Transportation, Warehousing), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

医疗保健物流市场规模与预测

2024 年医疗物流市场规模价值为 848.8 亿美元，预计到 2032 年将达到 1,793.1 亿美元，2026 年至 2032 年的复合年增长率为 9.68%。

医疗物流是一个复杂的系统，需要规划、管理和协调医疗物资、设备、药品、器官、组织甚至人员在正确的时间和地点条件下的运输。医疗物流与传统物流的不同之处在于，它处理的是生命攸关的产品，需要专门的处理和精准的交付时间。

这个专业领域可分为三个阶段：第一英里、中间英里和最后一英里。第一英里是将药品从製造商运送到分销点。中间英里专注于将这些货物运送到医院、诊所和药房。最后一哩路确保药品和设备在需要时直接送达患者手中。

高效的医疗物流对于确保病患的安全和健康至关重要。它确保医院和诊所拥有足够的物资，有效地治疗患者。及时送达药品，尤其是重症加护所需的药品，可能关乎生死。此外，对温度敏感的药品和疫苗必须妥善储存和运输，以保持其有效性。

医疗物流不仅对这些基本职能至关重要，对研发也至关重要。它促进了临床试验材料和生物样本的运输，加速了医学进步。此外，强大的物流系统对于血库、器官捐赠计画和紧急应变措施也至关重要。

全球医疗保健物流市场动态

影响全球医疗物流市场的关键市场动态是：

关键市场驱动因素

药品和医疗设备需求不断增长：全球药品和医疗设备市场的成长受到多种因素的推动。人口老化、医疗保健需求的不断增长以及慢性病的增多，推动了对药物和现代医疗设备的需求。此外，医学研发的进步也带来了新药和新技术的推出，推动了市场扩张。

技术进步：人工智慧 (AI)、区块链和物联网 (IoT) 等新兴技术的结合正在改变医疗物流。人工智慧解决方案可以改善库存管理，预测需求波动，并简化配送路线。区块链技术正在提高整个供应链的透明度和可追溯性，确保产品真实性并减少假冒产品。

注重成本效益和业务优化：医疗保健提供者和製药公司面临着在保持卓越服务水平的同时降低成本的压力。优化物流营运可以透过改善库存管理、减少浪费和提供高效的运输方案来降低成本。

策略伙伴关係与合作：物流和医疗保健公司越来越多地建立策略伙伴关係或联盟，利用第三方供应商的物流经验，使供应链更具弹性、更有效率、应对力市场。

主要问题

确保产品完整性并维持低温运输控制：医疗物流市场很大一部分涉及对温度敏感的产品，例如疫苗、血液製品、药品和生物样本。即使是轻微的温度波动也可能影响这些药物的功效和效用，并可能对患者健康造成不利影响。在整个供应链中（从製造到照护现场交付）保持稳定理想的温度仍然是一项重大挑战。

资料安全和隐私问题：医疗保健物流涉及处理敏感的病患数据，包括药品、医疗记录和保险资讯。网路安全威胁一直是该行业的焦点，资料外洩可能造成严重后果。投资强大的网路安全保障措施、为员工提供资料保护程序培训以及遵守严格的资料隐私法，对于保护敏感资讯至关重要。

应对「最后一公里」挑战：「最后一公里」——将医疗物资直接送达患者家中或护理机构——对医疗物流供应商构成了独特的挑战。地域分散、道路拥挤以及病患需求的多样化都会对配送时间和成本产生重大影响。开发创造性的「最后一公里」配送替代方案，例如使用无人机或与本地配送供应商合作，有助于克服这些问题。

劳动力短缺和营运成本上升：与许多其他企业一样，医疗物流企业也面临严重的人手不足。很难找到具备处理精密医疗产品所需经验的合格人员。这种人手不足可能导致供应链出现延误、效率低落和错误。

主要趋势

技术整合：物联网 (IoT)、区块链和人工智慧 (AI) 等先进技术正在医疗物流迅速应用，以提高供应链的效率、透明度和安全性。这些技术能够即时追踪药品和医疗设备，从而改善库存管理并降低仿冒品的风险。

低温运输物流：随着对生物製药和疫苗等温度敏感医疗产品的需求不断增加，对先进的低温运输低温运输物流物流的需求也在不断增加——配备温度监控系统的专用储存和运输设施，以确保从製造到分销的精密医疗产品的安全。

法规合规与品质保证：严格的法规，尤其是在医药物流，持续推动对合规和品质保证程序的投资。企业正在投资先进的追踪技术，以确保符合《药品分销规范》(GDP) 和《药品供应链安全法》等要求。

致力于永续性：环境永续性已成为医疗物流供应商的首要任务。他们越来越重视减少碳排放、消除废弃物并优化整个供应链的资源利用。相关措施包括使用环保包装材料、节能运输和回收计划。

目录

第一章 全球医疗物流市场简介

  • 市场定义
  • 市场区隔
  • 调查时间表
  • 先决条件
  • 限制

第 2 章 已验证的市场研究调查方法

  • 资料探勘
  • 数据三角测量
  • 自下而上的方法
  • 自上而下的方法
  • 调查流程
  • 业界专家的重要见解
  • 资料来源

第三章执行摘要

  • 市场概览
  • 生态测绘
  • 绝对的商机
  • 市场吸引力
  • 全球医疗物流市场的区域分析
  • 全球医疗物流市场（按产品类型划分）（百万美元）
  • 全球医疗物流市场（按服务划分）（百万美元）
  • 未来市场机会
  • 全球市场区隔
  • 产品生命线

第四章全球医疗物流市场展望

  • 全球医疗保健物流的演变
  • 驱动程式
    • 司机1
    • 司机2
  • 限制因素
    • 约束因素 1
    • 约束因素 2
  • 机会
    • 机会1
    • 机会2
  • 波特五力模型
  • 价值链分析
  • 定价分析
  • 宏观经济分析

第五章全球医疗物流市场（依产品类型）

  • 概述
  • 运输
  • 贮存

第六章 全球医疗物流市场（按服务）

  • 概述
  • 製药
  • 医疗设备

第七章全球医疗物流市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

第八章全球医疗物流市场的竞争格局

  • 概述
  • 各公司市场排名
  • 公司地理分布
  • 公司在各行业的足迹
  • ACE矩阵

第九章 公司简介

  • Deutsche Post DHL
  • Kuehne+Nagel
  • UPS（Marken）
  • DB Group
  • FedEx
  • Air Canada
  • AmerisourceBergen Corp.
  • CEVA Logistics AG
  • Continental Cargo OU
  • United Parcel Service Inc
  • Emerald Freight Express
  • Cavalier Logistics Management II, Inc.
  • Alloga
  • KERRY LOGISTICS NETWORK LIMITED
  • NIPPON EXPRESS CO., LTD.
  • Propeller Health
  • Cohero Health Inc.
  • GlaxoSmithKline
  • AstraZeneca plc
  • Novartis AG
  • 3M Company
  • Teva Pharmaceuticals
  • Vectura Group
  • Cognita Labs, Llc

第 11 章 已验证的市场情报

  • 关于已验证的市场情报
  • 动态资料视觉化
简介目录
Product Code: 50205

Healthcare Logistics Market Size And Forecast

Healthcare Logistics Market size was valued at USD 84.88 Billion in 2024 and is projected to reach USD 179.31 Billion by 2032, growing at a CAGR of 9.68% from 2026 to 2032.

Healthcare logistics is a complicated system of planning, managing, and coordinating the movement of medical supplies, equipment, medications, organs, tissues, and even individuals to the appropriate location, time, and condition. Healthcare logistics, unlike conventional logistics, deals with life-critical products that necessitate particular handling and exact delivery times.

This particular field can be divided into three stages: the first mile, the middle mile, and the final mile. The first mile entails transporting medicinal items from manufacturers to distribution sites. The middle mile focuses on delivering these goods to hospitals, clinics, and pharmacies. Finally, the last mile guarantees that medications and equipment are delivered directly to patients, as needed.

Efficient healthcare logistics are critical to guaranteeing patient safety and well-being. It ensures that hospitals and clinics have enough supplies to treat patients efficiently. The timely delivery of medications, particularly those required for critical care, might be the difference between life and death. Additionally, temperature-sensitive medications and vaccines must be stored and transported properly to maintain their potency.

Beyond these essential functions, healthcare logistics is critical for research and development. It makes it easier to move clinical trial materials and biological samples, which speeds up medical advances. Furthermore, robust logistical systems are vital for handling blood banks, organ donation programs, and emergency response measures.

Global Healthcare Logistics Market Dynamics

The key market dynamics that are shaping the global healthcare logistics market include:

Key Market Drivers:

Rising Demand for Pharmaceuticals and Medical Devices: Several factors contribute to the globally pharmaceutical and medical device sectors' growth. An aging population with increasing healthcare needs, combined with the rise in chronic diseases, is driving up demand for drugs and modern medical equipment. Furthermore, advances in medical research & development are resulting in the introduction of novel medications and technologies, which is driving market expansion.

Technological Advancements: The combination of advanced technologies such as artificial intelligence (AI), blockchain, and the Internet of Things (IoT) is transforming healthcare logistics. Artificial intelligence-powered solutions can improve inventory management, forecast demand variations, and streamline delivery routes. Blockchain technology improves transparency and traceability throughout the supply chain, ensuring product authenticity and reducing counterfeiting.

Focus on Cost Efficiency and Operational Optimization: Healthcare providers and pharmaceutical companies face pressure to save costs while maintaining excellent service levels. Optimizing logistics operations saves money by improving inventory management, reducing waste, and providing effective transportation options.

Strategic Partnerships and Collaborations: Logistics and healthcare firms are increasingly forming strategic partnerships and collaborations. These alliances use third-party suppliers' logistical experience to increase supply chain resilience, efficiency, and market response.

Key Challenges:

Ensure Product Integrity and Maintain Cold Chain Management: A substantial percentage of the healthcare logistics market is concerned with temperature-sensitive products such as vaccines, blood products, medications, and biological samples. Even modest temperature fluctuations can have an impact on the effectiveness and usefulness of these medications, potentially causing negative health repercussions for patients. Maintaining a stable and ideal temperature across the supply chain, from manufacture to point-of-care delivery, is still a substantial challenges.

Data Security and Privacy Concerns: Healthcare logistics entails dealing with sensitive patient data such as medicines, medical records, and insurance information. Cybersecurity threats are an ongoing worry for the sector, and data breaches can have disastrous effects. Investing in strong cybersecurity safeguards, providing employee training on data protection procedures, and adhering to tight data privacy legislation is essential for protecting sensitive information.

Managing the "Last Mile" Challenge: The "last mile," or delivering medical supplies directly to patients' homes or care facilities, provides a unique set of obstacles for healthcare logistics providers. Geographic dispersion, road congestion, and diverse patient needs all have a substantial impact on delivery times and costs. Developing creative last-mile delivery alternatives, such as using drones or cooperating with local delivery firms, can help to overcome these issues.

Labor Shortages and Rising Operational Costs: The healthcare logistics business, like many others, is experiencing a serious manpower shortage. Finding qualified individuals with the necessary experience to handle delicate medical items might be difficult. This scarcity may cause delays, inefficiencies, and errors in the supply chain.

Key Trends:

Technology Integration: Advanced technologies such as the Internet of Things (IoT), blockchain, and artificial intelligence (AI) are rapidly being used in healthcare logistics to improve supply chain efficiency, transparency, and security. These technologies offer real-time tracking of pharmaceuticals and medical devices, resulting in improved inventory management and a reduced risk of counterfeit products.

Cold Chain Logistics: As the need for temperature-sensitive medical products such as biopharmaceuticals and vaccines grows, so does the need for advanced cold chain logistics solutions. This comprises specialized storage and transportation facilities outfitted with temperature-monitoring systems to ensure the safety of sensitive healthcare products from manufacturing to delivery.

Regulatory Compliance and Quality Assurance: Stringent regulatory regulations, particularly in pharmaceutical logistics, continue to motivate investments in compliance and quality assurance procedures. Companies are investing in advanced tracking and tracing technologies to ensure compliance with requirements such as Good Distribution Practices (GDP) and the Drug Supply Chain Security Act.

Sustainability Initiatives: Environmental sustainability has become a top priority for healthcare logistics providers. Throughout the supply chain, there is an increasing emphasis on lowering carbon emissions, eliminating waste, and optimizing resource use. Initiatives include the use of environmentally friendly packaging materials, energy-efficient modes of transportation, and recycling programs.

Global Healthcare Logistics Market Regional Analysis

Here is a more detailed regional analysis of the global healthcare logistics market:

North America:

North America is the largest global healthcare logistics market shareholder and is expected to grow at a CAGR of 7.75% over the forecast period. As the region's senior population grows, so does the incidence of chronic diseases, creating a demand for modern healthcare products and services, as well as improved medical help, to effectively treat the growing number of chronic disease patients.

As a result, there is a higher demand in this region for safe and secure transportation of drugs, medical equipment, and devices. According to a 2017 WTO assessment, the United States is the world's second-largest exporter of medical products, with reported exports totaling USD 116 billion.

The United States is also the world's second-largest ventilator exporter and third-largest exporter of personal protection equipment. The high tolerance and open-mindedness of North American citizens has supported healthcare institutions in creating and implementing an abundance of novel healthcare supply chain technology.

Europe:

Europe is expected to have a CAGR of 7.33% throughout the projection period. Current healthcare operations in Europe include value-based care, cost and margin issues, and increasing regulatory and compliance requirements.

These factors encourage healthcare manufacturers to adjust their supply chain operations in order to remain competitive in the logistics market and continue to assist healthcare providers by prioritizing patients.

Within the European medical device sector, there are two primary markets: mature (Western Europe) and emerging (East Europe). To meet Europe's demand for medical devices and pharmaceuticals, producers and logistics providers must supply low-cost logistical services.

Because of the gravity of the COVID situation, the European healthcare industry is working around the clock to assure a steady supply of necessary pharmaceuticals, medical supplies, and protective equipment. These rules have an immediate and severe influence on internationally connected supply chains, which drives regional market expansion.

Global Healthcare Logistics Market: Segmentation Analysis

The Global Healthcare Logistics Market is Segmented on the basis of Service, and Product Type And Geography.

Healthcare Logistics Market, By Service

  • Pharmaceutical Products
  • Medical Devices

Based on Service, the market is bifurcated into Pharmaceutical Products, and Medical Devices. The pharmaceutical products segment is currently dominating the Healthcare Logistics Market. It is expected to have the largest share throughout the forecast period due to the huge volume and value of pharmaceuticals shipped internationally. However, the medical device market is expected to be the fastest-growing segment. This expansion is linked to rising demand for complicated medical devices and increased use of minimally invasive procedures.

Healthcare Logistics Market, By Product Type

  • Transportation
  • Warehousing

Based on Product Type, the market is fragmented into Transportation and Warehousing. Transportation is currently the most dominant segment. This is due to the vital transportation of medical supplies, drugs, and equipment that must be delivered on time and often saves lives. Efficient transportation ensures that these products reach healthcare professionals rapidly. Warehousing is the fastest-growing segment. This growth is being driven by the increased use of complicated biological medications and the growing necessity for temperature-controlled storage. Warehousing businesses are creating specialized facilities to suit these rigorous standards.

Healthcare Logistics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • On the basis of Geography, the Global Healthcare Logistics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America currently dominates the market due to its strong pharmaceutical and biopharmaceutical sectors and high healthcare spending. They maintain a consistent growth rate. Europe has a sizable stake, with an emphasis on innovative technologies and regulations. Growth is likely to remain constant.

Key Players

The "Global Healthcare Logistics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Deutsche Post DHL, Kuehne + Nagel, UPS (Marken), DB Group, FedEx, Air Canada, AmerisourceBergen Corp., CEVA Logistics AG, Continental Cargo OU, United Parcel Service Inc, Emerald Freight Express, Cavalier Logistics Management II, Inc., Alloga, KERRY LOGISTICS NETWORK LIMITED, and NIPPON EXPRESS CO., LTD., Adherium, Propeller Health, Cohero Health Inc., GlaxoSmithKline, AstraZeneca plc, Novartis AG, 3M Company, Teva Pharmaceuticals, Vectura Group, Cognita Labs, Llc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Healthcare Logistics Market Recent Developments
  • In November 2022, Cardinal Health announced the debut of VelocareTM, a supply chain network and last-mile fulfillment solution capable of delivering necessary materials and services required for hospital-level care to patients' homes in one to two hours.
  • In August 2022, United Parcel Service Inc announced that it will buy Bomi Group, an Italian healthcare logistics company, to improve its ability to transport drugs that require cold storage.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL HEALTHCARE LOGISTICS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Healthcare Logistics Market Geographical Analysis (CAGR %)
  • 3.6 Global Healthcare Logistics Market, By Product Type (USD Million)
  • 3.7 Global Healthcare Logistics Market, By Service (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL HEALTHCARE LOGISTICS MARKET OUTLOOK

  • 4.1 Global Healthcare Logistics Evolution
  • 4.2 Drivers
    • 4.2.1 Driver1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL HEALTHCARE LOGISTICS MARKET, BY PRODUCT TYPE

  • 5.1 Overview
  • 5.2 Transportation
  • 5.3 Warehousing

6 GLOBAL HEALTHCARE LOGISTICS MARKET, BY SERVICE

  • 6.1 Overview
  • 6.2 Pharmaceutical Products
  • 6.3 Medical devices

7 GLOBAL HEALTHCARE LOGISTICS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL HEALTHCARE LOGISTICS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Deutsche Post DHL
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Development
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Kuehne + Nagel
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Development
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 UPS (Marken)
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Development
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 DB Group
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Development
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 FedEx
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Development
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Air Canada
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Development
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 AmerisourceBergen Corp.
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Development
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 CEVA Logistics AG
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Development
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 Continental Cargo OU
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Development
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 United Parcel Service Inc
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Development
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis
  • 9.11 Emerald Freight Express
    • 9.11.1 Company Overview
    • 9.11.2 Company Insights
    • 9.11.3 Product Benchmarking
    • 9.11.4 Key Development
    • 9.11.5 Winning Imperatives
    • 9.11.6 Current Focus & Strategies
    • 9.11.7 Threat from Competition
    • 9.11.8 SWOT Analysis
  • 9.12 Cavalier Logistics Management II, Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Insights
    • 9.12.3 Product Benchmarking
    • 9.12.4 Key Development
    • 9.12.5 Winning Imperatives
    • 9.12.6 Current Focus & Strategies
    • 9.12.7 Threat from Competition
    • 9.12.8 SWOT Analysis
  • 9.13 Alloga
    • 9.13.1 Company Overview
    • 9.13.2 Company Insights
    • 9.13.3 Product Benchmarking
    • 9.13.4 Key Development
    • 9.13.5 Winning Imperatives
    • 9.13.6 Current Focus & Strategies
    • 9.13.7 Threat from Competition
    • 9.13.8 SWOT Analysis
  • 9.14 KERRY LOGISTICS NETWORK LIMITED
    • 9.14.1 Company Overview
    • 9.14.2 Company Insights
    • 9.14.3 Product Benchmarking
    • 9.14.4 Key Development
    • 9.14.5 Winning Imperatives
    • 9.14.6 Current Focus & Strategies
    • 9.14.7 Threat from Competition
    • 9.14.8 SWOT Analysis
  • 9.15 NIPPON EXPRESS CO., LTD.
    • 9.15.1 Company Overview
    • 9.15.2 Company Insights
    • 9.15.3 Product Benchmarking
    • 9.15.4 Key Development
    • 9.15.5 Winning Imperatives
    • 9.15.6 Current Focus & Strategies
    • 9.15.7 Threat from Competition
    • 9.15.8 SWOT Analysis
  • 9.16 Propeller Health
    • 9.16.1 Company Overview
    • 9.16.2 Company Insights
    • 9.16.3 Product Benchmarking
    • 9.16.4 Key Development
    • 9.16.5 Winning Imperatives
    • 9.16.6 Current Focus & Strategies
    • 9.16.7 Threat from Competition
    • 9.16.8 SWOT Analysis
  • 9.17 Cohero Health Inc.
    • 9.17.1 Company Overview
    • 9.17.2 Company Insights
    • 9.17.3 Product Benchmarking
    • 9.17.4 Key Development
    • 9.17.5 Winning Imperatives
    • 9.17.6 Current Focus & Strategies
    • 9.17.7 Threat from Competition
    • 9.17.8 SWOT Analysis
  • 9.18 GlaxoSmithKline
    • 9.18.1 Company Overview
    • 9.18.2 Company Insights
    • 9.18.3 Product Benchmarking
    • 9.18.4 Key Development
    • 9.18.5 Winning Imperatives
    • 9.18.6 Current Focus & Strategies
    • 9.18.7 Threat from Competition
    • 9.18.8 SWOT Analysis
  • 9.19 AstraZeneca plc
    • 9.19.1 Company Overview
    • 9.19.2 Company Insights
    • 9.19.3 Product Benchmarking
    • 9.19.4 Key Development
    • 9.19.5 Winning Imperatives
    • 9.19.6 Current Focus & Strategies
    • 9.19.7 Threat from Competition
    • 9.19.8 SWOT Analysis
  • 9.20 Novartis AG
    • 9.20.1 Company Overview
    • 9.20.2 Company Insights
    • 9.20.3 Product Benchmarking
    • 9.20.4 Key Development
    • 9.20.5 Winning Imperatives
    • 9.20.6 Current Focus & Strategies
    • 9.20.7 Threat from Competition
    • 9.20.8 SWOT Analysis
  • 9.21 3M Company
    • 9.21.1 Company Overview
    • 9.21.2 Company Insights
    • 9.21.3 Product Benchmarking
    • 9.21.4 Key Development
    • 9.21.5 Winning Imperatives
    • 9.21.6 Current Focus & Strategies
    • 9.21.7 Threat from Competition
    • 9.21.8 SWOT Analysis
  • 9.22 Teva Pharmaceuticals
    • 9.22.1 Company Overview
    • 9.22.2 Company Insights
    • 9.22.3 Product Benchmarking
    • 9.22.4 Key Development
    • 9.22.5 Winning Imperatives
    • 9.22.6 Current Focus & Strategies
    • 9.22.7 Threat from Competition
    • 9.22.8 SWOT Analysis
  • 9.23 Vectura Group
    • 9.23.1 Company Overview
    • 9.23.2 Company Insights
    • 9.23.3 Product Benchmarking
    • 9.23.4 Key Development
    • 9.23.5 Winning Imperatives
    • 9.23.6 Current Focus & Strategies
    • 9.23.7 Threat from Competition
    • 9.23.8 SWOT Analysis
  • 9.24 Cognita Labs, Llc
    • 9.24.1 Company Overview
    • 9.24.2 Company Insights
    • 9.24.3 Product Benchmarking
    • 9.24.4 Key Development
    • 9.24.5 Winning Imperatives
    • 9.24.6 Current Focus & Strategies
    • 9.24.7 Threat from Competition
    • 9.24.8 SWOT Analysis

11. VERIFIED MARKET INTELLIGENCE

  • 11.1 About Verified Market Intelligence
  • 11.2 Dynamic Data Visualization